Six jaundiced patients with primary sclerosing cholangitis and a dominant biliary stricture were managed by endoscopic placement of endoprostheses. Five 
(range) 266 imolUl (63-681) to 65 [imol/l (10- '6 who reported that percutaneous balloon cholangioplasty of intra-and extrahepatic ducts in 15 patients with primary sclerosing cholangitis required an average of 3-7 sessions and a mean (range) of 8-9 hours (4-18). In addition, it is associated with bacteraemia and intrapleural or intrabiliary haemorrhage in a significant proportion of patients. 14 1I
Huibregtse and Tytgat2' first described the management of primary sclerosing cholangitis strictures by endoscopic stenting after a sphincterotomy and have since described sustained improvement in 13 of 16 patients treated in this way. 26 Siegal and Guelrud`performed endoscopic balloon dilatation for strictures in two patients with primary sclerosing cholangitis, and Johnson et al8 performed sphincterotomy in 10, subsequently dilating eight and stenting three. In Johnson's series, patients' liver biochemistry improved and the number of admissions to hospital for cholangitis was reduced over a two year follow up period, but one patient developed peritonitis as a result of sphincterotomy. We chose to avoid a sphincterotomy whenever feasable because of the long term risks of bacterial colonisation.`9 Three of our patients (50%) had septic complications, in two attributable to distension of the gall bladder at cholangiography with subsequent obstruction to emptying by the endoprosthesis. This is a complication that can be difficult to avoid in primary sclerosing cholangitis because of the extensive strictures and the relatively high filling pressures required to obtain a cholangiogram.
To date, there is insufficient experience to determine how long stents should be left in place. Some advocate leaving a percutaneous endoprosthesis in place for 12-16 months'3 21 but others have reported such poor tolerance that the mean duration was <6 months. '6 Huibregtse26 removed the endoprosthesis permanently in eight of 16 patients without detectable deterioration at follow up. In four of our patients the endoprostheses have been removed and the patients remain well with continued improvement in the radiological assessment of disease. In one other patient the stricture recurred after removal of the endoprosthesis at four months. This patient's clinical condition deteriorated subsequently but the deterioration was reversed with further endoprosthesis insertion. That dramatic radiological improvement can be achieved even with short term stenting (see Fig  2) , confirms a previous report of long term age are ultimately palliative in this condition and that most patients with primary sclerosing cholangitis will eventually require liver transplantation. With this in mind, endoscopic placement of endoprosthesis seems to be the drainage procedure ofchoice as it may avoid the disadvantages of surgical or percutaneous methods. A coordinated multicentre prospective study is required to assess the best means of biliary intervention in these patients and to determine whether broader criteria for such intervention are justified. 
